Shimoyama, Naohito <br/><br/>
Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain.  [electronic resource] 

 -  Japanese journal of clinical oncology  Feb 2015 
 - 189-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-3621 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyu182  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Administration, Sublingual<br/>Adult<br/>Aged<br/>Analgesics, Opioid--administration & dosage<br/>Breakthrough Pain--drug therapy<br/>Chronic Pain--drug therapy<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Fentanyl--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Morphine--administration & dosage<br/>Neoplasms--complications<br/>Pain Measurement<br/>Patient Selection<br/>Severity of Illness Index<br/>Tablets<br/>Treatment Outcome